BDX vs. MDLN: Becton, Dickinson vs. Medline Stock Comparison

Company Profile

Becton, Dickinson (BDX) and Medline (MDLN) both belong to the Health Care Equipment & Supplies industry, though BDX is classified under Health Care Equipment while MDLN falls under Health Care Supplies.

Becton, Dickinson (BDX) has been public since February 21, 1973, giving it decades of market history across multiple cycles, while Medline (MDLN) listed only on December 17, 2025 and lacks comparable through-cycle data.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Medline (MDLN) reports a negative beta of -0.93, suggesting inverse market sensitivity over the measurement window. That is uncommon for ordinary equities and can reflect commodity-linked or hedge-like exposure, but it can also come from statistical noise. Becton, Dickinson (BDX) has a non-negative beta of 0.19.

Risk-Adjusted Performance

Risk-Return Positioning

Both BDX and MDLN need 1-year volatility and 1-year return to plot risk-return positioning.

Risk-Adjusted Metrics

Profitability

Both Becton, Dickinson (BDX) at 5.66% and Medline (MDLN) at 4.85% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

Both Becton, Dickinson (BDX) at 5.89% and Medline (MDLN) at 1.85% keep about the typical share of revenue as profit for their industries — neither bottom line stands out from peers.

Becton, Dickinson (BDX) at 21.63% operates in the top operating margin quartile, ahead of Medline (MDLN) at 5.22%, which runs around its industry’s norm.

Profitability Metrics

Growth

Only one side can be read here: Becton, Dickinson (BDX) reports revenue growth of 8.24%, ranked against its industry; Medline (MDLN) has no revenue growth figure this period.

Medline (MDLN) at 117.38% clears its industry range for EPS growth, a much stronger earnings trajectory than Becton, Dickinson (BDX) at -1.86%, which is closer to a typical peer reading.

Growth Metrics

Financial Strength

Medline (MDLN) at 4.04 carries current ratio above its industry’s typical mid-range, while Becton, Dickinson (BDX) at 0.87 runs in the tighter-liquidity quartile — different working-capital profiles, both worth examining.

Both Becton, Dickinson (BDX) at 0.66 and Medline (MDLN) at 0.65 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Neither Becton, Dickinson (BDX) nor Medline (MDLN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Medline (MDLN) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Becton, Dickinson (BDX) reports a payout of 72.49%, ranking against industry peers normally.

Dividend Metrics

Valuation

Becton, Dickinson (BDX) at 41.87 is near its industry’s usual P/E ratio, while Medline (MDLN) at 90.09 sits above its peer range — an unusually expensive price for MDLN’s trailing earnings.

On P/S ratio, both Becton, Dickinson (BDX) at 2.97 and Medline (MDLN) at 1.70 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

On P/B ratio, both Becton, Dickinson (BDX) at 2.34 and Medline (MDLN) at 2.95 are valued close to their industries’ norm against book — neither stands out from peers.

Valuation Metrics